Preoperative Statin Use and Major Adverse Cardiovascular Events in Liver Transplant Recipients

The goal of this multicenter observational study is to determine whether preoperative statin use reduces major adverse cardiovascular events or other complications after liver transplantation. The main question it aims to answer is: Does preoperative statin use reduce major adverse cardiovascular events or other complications after liver transplantation? The records of participants who already took statins before liver transplantation will be reviewed.

NCT Number	NCT07089589
Lead Sponsor	Asan Medical Center Collaborators: Samsung Medical Center, Inje University Haeundae Paik Hospital
Conditions	Major Adverse Cardiovascular Events, Liver Transplantation
Enrollment	6,898 participants
Start Date	2008-01-02
Primary Completion	2026-01-25 (estimated)
Study Completion	2026-03-22 (estimated)
Updated on ClinicalTrials.gov	2026-04-08